Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the period of May 2026, specifically reporting on a Special General Meeting of Shareholders held on May 11, 2026. The meeting was initially adjourned due to a lack of quorum at 5:00 p.m. Israel time but was successfully reconvened at 6:30 p.m. with a quorum present.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance proceedings and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are disclosed in this document. The primary event reported is the successful approval of the agenda item described in the Company's proxy statement filed on April 22, 2026, following the initial failure to achieve a quorum.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, or specific risks. It notes that the report is incorporated by reference into the Company's Registration Statements on Form F-3 and Form S-8. The only operational detail provided is the procedural delay in the shareholder meeting.
Key Facts for Investor Verification
- Verify the specific agenda item approved by shareholders by reviewing the Proxy Statement filed on April 22, 2026 (Exhibit 99.2).
- Confirm the voting results and attendance details from the adjourned meeting held at 6:30 p.m. Israel time.
- Check subsequent filings for financial data, as this Form 6-K contains no financial metrics.